IL10 and cancer: Suppression by IL-10 of antitumor immunity mechanisms (preventing antigen presentation from transformed cancer cells to cytotoxic T cells) favors propagation of the cancer and reduces patient survival [94,95]; IL-10 can therefore serve as a prognostic biomarker, especially at early stages of the disease.